Home
Technical
Publications
Molecular docking and in vivo studies of liquiritin against acute myocardial infarction via TLR4/MyD88/NF-κB signaling(ABP51952-1)

Molecular docking and in vivo studies of liquiritin against acute myocardial infarction via TLR4/MyD88/NF-κB signaling(ABP51952-1)

Date：2026-03-03 Views：64

Prev：Molecular Mechanism of Aluminum-Induced Oxidative Damage and Apoptosis in Rat Cardiomyocytes(A01020-3)

Next：Molecular Mechanism of MYL4 Regulation of Skeletal Muscle Development in Pigs(A23210-4)

RECEIVE OFFERS BY EMAIL

CONTACT US

Welcome any form of communications, and better service will be provided here.

Tell： +1-404-854-0155

Email： service@abbkine.com

Support Email： support@abbkine.com

Address： 3052 Stroop Hill Road, Apt 203, Atlanta 30303, Georgia, United States of America

Links：

Copyright © 2012 - 2017 Abbkine, Inc. - All rights reserved